PMID: 8943046Nov 26, 1996Paper

Modifying the sequence of an immunoglobulin V-gene alters the resulting pattern of hypermutation

Proceedings of the National Academy of Sciences of the United States of America
B Goyenechea, C Milstein

Abstract

Affinity maturation of antibodies requires localized hypermutation and antigen selection. Hypermutation is particularly active in certain regions (notably the CDRs of light and heavy chains) due to the local accumulation of hot spots. We have now analyzed the role of individual nucleotides in the origin of hot spots and show that mutability is largely defined by the nucleotide sequence. We compared the mutability profile of wild-type and modified kappa transgenes that contain silent mutations in the CDR1 segment. We found a new hot spot created at the third base of Ser-31 when its wild-type AGT codon was substituted by AGC. Two major hot spots associated with this AGC vanished when Ser-31 was encoded by the synonymous TCA. In addition to these, which were the most prominent changes, there were compensatory alterations in mutability of residues not directly related to the introduced silent mutations, so that the average hypermutation remained constant. Thus, mutations arising early in the immune response, even silent ones, could affect the mutability of critical residues and alter the pattern of affinity maturation. When analyzing hybridomas, we detected such alterations, but they seemed to better correlate with changes in avera...Continue Reading

References

Jan 27, 1977·Nature·K AdetugboD S Secher
Jan 1, 1977·Immunological Reviews·D S SecherK Adetugbo
Apr 1, 1992·Immunological Reviews·I C MacLennanG D Johnson
Oct 1, 1990·Molecular and Cellular Biology·G W BothE J Steele
Oct 1, 1988·Immunological Reviews·C Berek, C Milstein
Apr 1, 1987·Immunological Reviews·C Berek, C Milstein
Jan 1, 1987·Genetics·G B GoldingB W Glickman
May 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·D McKeanM Weigert
Jun 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·P J Gearhart, D F Bogenhagen
Jan 1, 1981·Methods in Enzymology·G Galfrè, C Milstein
Apr 1, 1995·Current Opinion in Immunology·M S Neuberger, C Milstein
Aug 31, 1995·Nature·S D WagnerM S Neuberger
Jun 9, 1995·Journal of Molecular Biology·Y L ChuiC Milstein
Dec 23, 1994·Science·P C Hanawalt
Dec 20, 1994·Proceedings of the National Academy of Sciences of the United States of America·A González-FernándezC Milstein
Mar 1, 1995·Mutation Research·P C Hanawalt
Jul 1, 1994·The Journal of Experimental Medicine·V PascualJ D Capra
Jun 1, 1994·European Journal of Immunology·C RadaC Milstein
Nov 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·A González-Fernández, C Milstein
Sep 7, 1993·Journal of Theoretical Biology·T B Kepler, A S Perelson
May 13, 1993·Nature·D Bootsma, J H Hoeijmakers
Jun 1, 1996·European Journal of Immunology·F Celada, P E Seiden
Jun 1, 1996·Seminars in Immunology·C J JollyM S Neuberger

❮ Previous
Next ❯

Citations

Jun 19, 1998·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·N S GreenM D Scharff
Mar 21, 2000·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·L H Caporale
Aug 29, 2003·Molecular Immunology·Gary S ShapiroLawrence J Wysocki
Sep 29, 1999·Immunology Today·F J Stevens, Y Argon
May 14, 1999·Current Opinion in Immunology·M WablC Steinberg
Mar 30, 1999·Mutation Research·R S HarrisN Maizels
May 29, 2001·Nature Immunology·I B RogozinT A Kunkel
Jan 31, 1998·The Journal of Experimental Medicine·P C WilsonV Pascual
May 29, 1998·Immunological Reviews·Q KongN Maizels
May 29, 1998·Immunological Reviews·N S GreenM D Scharff
May 29, 1998·Immunological Reviews·M S NeubergerC Milstein
May 29, 1998·Immunological Reviews·G D WiensM B Rittenberg
Jul 23, 1999·Annals of the New York Academy of Sciences·L H Caporale
Feb 28, 2002·Annual Review of Immunology·Tasuku HonjoMasamichi Muramatsu
May 1, 2006·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Tasuku HonjoReiko Shinkura
May 13, 1997·Proceedings of the National Academy of Sciences of the United States of America·M M LinM D Scharff
May 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·Cristina RadaCésar Milstein
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·C MilsteinR Staden
Apr 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·J BachlM Wabl
Apr 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·T GoossensR Küppers
Nov 18, 2008·Veterinary Immunology and Immunopathology·Azad K KaushikSurinder S Saini
Jan 31, 2017·Immunological Reviews·Peter D KwongLawrence Shapiro
Jun 29, 1999·Nature Biotechnology·P S Chowdhury, I Pastan
Feb 17, 1998·European Journal of Immunology·J BachlM Wabl
Dec 7, 2016·Frontiers in Immunology·Thiago DetanicoLawrence J Wysocki
Jul 28, 2017·Proceedings of the National Academy of Sciences of the United States of America·Joyce K HwangFrederick W Alt
Aug 30, 2019·International Journal of Molecular Sciences·Xin ChengHe Huang
Oct 19, 2001·Oncogene·R Küppers, R Dalla-Favera

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.